Insider Transactions for Deciphera Pharmaceuticals, Inc. (DCPH)

Symbol CompanyOwnerRelationshipDateTransactionCost# SharesValue ($)Total SharesFiling
DCPHDeciphera Pharmaceuticals, Inc.Kelly Thomas PatrickChief Financial OfficerFeb 16, 2024Sale$15.623,01047,00980,350Feb 20, 2024, 04:05 PM
DCPHDeciphera Pharmaceuticals, Inc.Pitman JamaSVP, Chief Development OfficerFeb 16, 2024Sale$15.622,26735,40568,031Feb 20, 2024, 04:05 PM
DCPHDeciphera Pharmaceuticals, Inc.Martin Daniel C.Chief Commercial OfficerFeb 16, 2024Sale$15.622,26735,40555,118Feb 20, 2024, 04:05 PM
DCPHDeciphera Pharmaceuticals, Inc.Brightstar Associates LLC10% OwnerFeb 07, 2024Option Exercise$0.01000914,0019,14023,059,708Feb 09, 2024, 04:30 PM
DCPHDeciphera Pharmaceuticals, Inc.Sherman Matthew LEVP & Chief Medical OfficerJan 16, 2024Sale$14.472,43535,23494,079Jan 18, 2024, 04:15 PM
DCPHDeciphera Pharmaceuticals, Inc.Pitman JamaSVP, Chief Development OfficerJan 16, 2024Sale$14.471,62423,49950,573Jan 18, 2024, 04:15 PM
DCPHDeciphera Pharmaceuticals, Inc.Kelly Thomas PatrickChief Financial OfficerJan 16, 2024Sale$14.472,43535,23466,085Jan 18, 2024, 04:15 PM
DCPHDeciphera Pharmaceuticals, Inc.Martin Daniel C.Chief Commercial OfficerJan 16, 2024Sale$14.471,62423,49947,660Jan 18, 2024, 04:15 PM
DCPHDeciphera Pharmaceuticals, Inc.Hoerter Steven L.President and CEODec 13, 2023Sale$15.3730,664471,21772,763Dec 14, 2023, 04:05 PM
DCPHDeciphera Pharmaceuticals, Inc.Kelly Thomas PatrickChief Financial OfficerDec 13, 2023Sale$15.372,79242,90568,520Dec 14, 2023, 04:05 PM
DCPHDeciphera Pharmaceuticals, Inc.Pitman JamaSee RemarksDec 13, 2023Sale$15.371,66225,54052,197Dec 14, 2023, 04:05 PM
DCPHDeciphera Pharmaceuticals, Inc.Martin Daniel C.Chief Commercial OfficerDec 13, 2023Sale$15.371,72726,53949,284Dec 14, 2023, 04:05 PM
DCPHDeciphera Pharmaceuticals, Inc.Sherman Matthew LEVP & Chief Medical OfficerDec 13, 2023Sale$15.372,79242,90596,514Dec 14, 2023, 04:05 PM
DCPHDeciphera Pharmaceuticals, Inc.Martin Daniel C.Chief Commercial OfficerNov 30, 2023Sale$12.5717,801223,75545,435Dec 01, 2023, 04:05 PM
DCPHDeciphera Pharmaceuticals, Inc.Sherman Matthew LEVP & Chief Medical OfficerOct 30, 2023Sale$12.022,36028,36290,628Oct 31, 2023, 04:11 PM
DCPHDeciphera Pharmaceuticals, Inc.Pitman JamaSee RemarksOct 30, 2023Sale$12.021,40716,90948,283Oct 31, 2023, 04:10 PM
DCPHDeciphera Pharmaceuticals, Inc.Martin Daniel C.Chief Commercial OfficerOct 30, 2023Sale$12.021,40716,90962,884Oct 31, 2023, 04:10 PM
DCPHDeciphera Pharmaceuticals, Inc.Kelly Thomas PatrickChief Financial OfficerOct 30, 2023Sale$12.022,31627,83363,068Oct 31, 2023, 04:09 PM
DCPHDeciphera Pharmaceuticals, Inc.Hoerter Steven L.President and CEOOct 30, 2023Sale$12.0221,573259,25640,927Oct 31, 2023, 04:09 PM
DCPHDeciphera Pharmaceuticals, Inc.Sherman Matthew LEVP & Chief Medical OfficerOct 02, 2023Sale$12.682,94237,30584,744Oct 04, 2023, 04:05 PM
DCPHDeciphera Pharmaceuticals, Inc.Pitman JamaSee RemarksJun 16, 2023Sale$14.401,23817,82943,812Jun 21, 2023, 04:05 PM
DCPHDeciphera Pharmaceuticals, Inc.Sherman Matthew LEVP & Chief Medical OfficerJun 16, 2023Sale$14.401,65523,83587,686Jun 21, 2023, 04:05 PM
DCPHDeciphera Pharmaceuticals, Inc.Kelly Thomas PatrickChief Financial OfficerJun 16, 2023Sale$14.401,65523,83557,140Jun 21, 2023, 04:05 PM
DCPHDeciphera Pharmaceuticals, Inc.Martin Daniel C.Chief Commercial OfficerJun 16, 2023Sale$14.401,23817,82958,413Jun 21, 2023, 04:05 PM
DCPHDeciphera Pharmaceuticals, Inc.Flynn Daniel LeeChief Scientific OfficerJun 16, 2023Sale$14.401,65523,83557,158Jun 21, 2023, 04:05 PM
DCPHDeciphera Pharmaceuticals, Inc.Friedman Franklin StuartDirectorJun 08, 2023Buy$13.8810,000138,82810,000Jun 12, 2023, 04:05 PM
DCPHDeciphera Pharmaceuticals, Inc.Walsh Dennis LeoDirectorMay 10, 2023Buy$13.8611,000152,41611,000May 12, 2023, 04:05 PM
DCPHDeciphera Pharmaceuticals, Inc.Hoerter Steven L.President and CEOMar 21, 2023Sale$15.577,500116,7820Mar 23, 2023, 04:05 PM
DCPHDeciphera Pharmaceuticals, Inc.Brightstar Associates LLC10% OwnerFeb 28, 2023Option Exercise$0.010002,427,69324,27722,145,707Mar 01, 2023, 04:15 PM
DCPHDeciphera Pharmaceuticals, Inc.Pitman JamaSee RemarksFeb 16, 2023Sale$15.101,15917,50045,050Feb 17, 2023, 04:14 PM
DCPHDeciphera Pharmaceuticals, Inc.Martin Daniel C.Chief Commercial OfficerFeb 16, 2023Sale$15.101,15917,50058,381Feb 17, 2023, 04:12 PM
DCPHDeciphera Pharmaceuticals, Inc.Kelly Thomas PatrickChief Financial OfficerFeb 16, 2023Sale$15.101,37020,68658,795Feb 17, 2023, 04:09 PM
DCPHDeciphera Pharmaceuticals, Inc.Sherman Matthew LEVP & Chief Medical OfficerFeb 16, 2023Sale$15.1097114,66188,145Feb 17, 2023, 04:07 PM
DCPHDeciphera Pharmaceuticals, Inc.Flynn Daniel LeeChief Scientific OfficerFeb 16, 2023Sale$15.101,37020,68658,813Feb 17, 2023, 04:04 PM
DCPHDeciphera Pharmaceuticals, Inc.Hoerter Steven L.President and CEOFeb 14, 2023Sale$16.0030,045480,7207,500Feb 16, 2023, 04:18 PM
DCPHDeciphera Pharmaceuticals, Inc.Brightstar Associates LLC10% OwnerJan 24, 2023Buy$18.001,666,66629,999,98819,718,014Jan 24, 2023, 06:20 PM
DCPHDeciphera Pharmaceuticals, Inc.Flynn Daniel LeeChief Scientific OfficerJan 17, 2023Sale$21.242,40351,04343,695Jan 19, 2023, 04:06 PM
DCPHDeciphera Pharmaceuticals, Inc.Pitman JamaSee RemarksJan 17, 2023Sale$21.241,60334,05035,058Jan 19, 2023, 04:06 PM
DCPHDeciphera Pharmaceuticals, Inc.Sherman Matthew LEVP & Chief Medical OfficerJan 17, 2023Sale$21.242,40351,04372,628Jan 19, 2023, 04:05 PM
DCPHDeciphera Pharmaceuticals, Inc.Martin Daniel C.Chief Commercial OfficerJan 17, 2023Sale$21.241,60334,05048,389Jan 19, 2023, 04:05 PM
DCPHDeciphera Pharmaceuticals, Inc.Kelly Thomas PatrickChief Financial OfficerJan 17, 2023Sale$21.242,40351,04343,677Jan 19, 2023, 04:05 PM
DCPHDeciphera Pharmaceuticals, Inc.Sherman Matthew LEVP & Chief Medical OfficerOct 03, 2022Sale$18.732,58748,45574,297Oct 05, 2022, 04:05 PM
DCPHDeciphera Pharmaceuticals, Inc.Sherman Matthew LEVP & Chief Medical OfficerJun 16, 2022Sale$10.751,76819,00676,884Jun 21, 2022, 04:37 PM
DCPHDeciphera Pharmaceuticals, Inc.Pitman JamaSee RemarksJun 16, 2022Sale$10.751,29813,95436,661Jun 21, 2022, 04:36 PM
DCPHDeciphera Pharmaceuticals, Inc.Martin Daniel C.Chief Commercial OfficerJun 16, 2022Sale$10.751,31114,09349,521Jun 21, 2022, 04:35 PM
DCPHDeciphera Pharmaceuticals, Inc.Kelly Thomas PatrickChief Financial OfficerJun 16, 2022Sale$10.751,76819,00646,080Jun 21, 2022, 04:35 PM
DCPHDeciphera Pharmaceuticals, Inc.Flynn Daniel LeeChief Scientific OfficerJun 16, 2022Sale$10.751,76819,00646,098Jun 21, 2022, 04:34 PM
DCPHDeciphera Pharmaceuticals, Inc.Brightstar Associates LLC10% OwnerApr 29, 2022Buy$10.001,478,97814,789,78018,051,348Apr 29, 2022, 04:31 PM
DCPHDeciphera Pharmaceuticals, Inc.Hoerter Steven L.President and CEOMar 21, 2022Option Exercise$9.113,15028,69637,545Mar 23, 2022, 04:15 PM
DCPHDeciphera Pharmaceuticals, Inc.Flynn Daniel LeeChief Scientific OfficerFeb 16, 2022Sale$9.051,36612,36247,866Feb 18, 2022, 05:01 PM
DCPHDeciphera Pharmaceuticals, Inc.Martin Daniel C.Chief Commercial OfficerFeb 16, 2022Sale$9.051,14610,37148,668Feb 18, 2022, 05:01 PM
DCPHDeciphera Pharmaceuticals, Inc.Sherman Matthew LEVP & Chief Medical OfficerFeb 16, 2022Sale$9.059848,90576,790Feb 18, 2022, 05:01 PM
DCPHDeciphera Pharmaceuticals, Inc.Kelly Thomas PatrickChief Financial OfficerFeb 16, 2022Sale$9.051,36812,38047,848Feb 18, 2022, 05:01 PM
DCPHDeciphera Pharmaceuticals, Inc.Pitman JamaSee RemarksFeb 16, 2022Sale$9.051,14610,37137,959Feb 18, 2022, 05:00 PM
DCPHDeciphera Pharmaceuticals, Inc.Sherman Matthew LEVP & Chief Medical OfficerOct 04, 2021Sale$33.172,65988,19946,029Oct 06, 2021, 04:00 PM
DCPHDeciphera Pharmaceuticals, Inc.Bristol James ArthurDirectorApr 12, 2021Sale$23.8929,400702,47614,700Apr 14, 2021, 04:00 PM
DCPHDeciphera Pharmaceuticals, Inc.Taylor Michael DouglasDirectorApr 01, 2021Sale$23.7316,000379,6928,000Apr 06, 2021, 06:00 AM
DCPHDeciphera Pharmaceuticals, Inc.Hoerter Steven L.President and CEOMar 18, 2021Option Exercise$43.023,150135,50043,145Mar 22, 2021, 05:00 PM
DCPHDeciphera Pharmaceuticals, Inc.Taylor Michael DouglasDirectorMar 01, 2021Sale$22.9616,000367,4278,000Mar 03, 2021, 12:00 AM
DCPHDeciphera Pharmaceuticals, Inc.Kelly Thomas PatrickChief Financial OfficerFeb 16, 2021Sale$48.8752425,6086,516Feb 18, 2021, 07:00 PM
DCPHDeciphera Pharmaceuticals, Inc.Flynn Daniel LeeChief Scientific OfficerFeb 16, 2021Sale$48.8750824,8266,532Feb 18, 2021, 07:00 PM
DCPHDeciphera Pharmaceuticals, Inc.Sherman Matthew LEVP & Chief Medical OfficerFeb 16, 2021Sale$48.871326,45137,286Feb 18, 2021, 07:00 PM
DCPHDeciphera Pharmaceuticals, Inc.Taylor Michael DouglasDirectorFeb 01, 2021Sale$23.5616,000376,9928,000Feb 03, 2021, 12:00 AM
DCPHDeciphera Pharmaceuticals, Inc.Hoerter Steven L.President and CEOJan 21, 2021Option Exercise$25.401,07827,38143,845Jan 25, 2021, 05:00 PM
DCPHDeciphera Pharmaceuticals, Inc.Bristol James ArthurDirectorJan 15, 2021Sale$27.1214,000379,6897,000Jan 20, 2021, 04:00 PM
DCPHDeciphera Pharmaceuticals, Inc.Taylor Michael DouglasDirectorJan 04, 2021Sale$29.1738,0001,108,40719,000Jan 06, 2021, 04:10 PM
DCPHDeciphera Pharmaceuticals, Inc.Sherman Matthew LEVP & Chief Medical OfficerDec 09, 2020Option Exercise$34.432077,12737,418Dec 11, 2020, 04:10 PM
DCPHDeciphera Pharmaceuticals, Inc.Taylor Michael DouglasDirectorDec 01, 2020Sale$31.4038,0001,193,05219,000Dec 03, 2020, 04:15 PM
DCPHDeciphera Pharmaceuticals, Inc.Sherman Matthew LEVP & Chief Medical OfficerNov 16, 2020Option Exercise$34.432,69792,85837,211Nov 18, 2020, 07:31 PM
DCPHDeciphera Pharmaceuticals, Inc.Taylor Michael DouglasDirectorNov 04, 2020Sale$33.3430,0001,000,33715,000Nov 06, 2020, 04:00 PM
DCPHDeciphera Pharmaceuticals, Inc.Taylor Michael DouglasDirectorNov 02, 2020Sale$29.7746,6301,387,99223,315Nov 04, 2020, 04:10 PM
DCPHDeciphera Pharmaceuticals, Inc.Bristol James ArthurDirectorOct 09, 2020Sale$27.7347,0821,305,56123,541Oct 13, 2020, 04:20 PM
DCPHDeciphera Pharmaceuticals, Inc.Sherman Matthew LEVP & Chief Medical OfficerOct 02, 2020Option Exercise$51.152,632134,61834,128Oct 06, 2020, 04:00 PM
DCPHDeciphera Pharmaceuticals, Inc.Taylor Michael DouglasDirectorOct 01, 2020Sale$26.75250,0006,686,734125,000Oct 05, 2020, 12:00 AM
DCPHDeciphera Pharmaceuticals, Inc.Kelly Thomas PatrickChief Financial OfficerSep 14, 2020Option Exercise$25.956,000155,70610,040Sep 16, 2020, 04:00 PM
DCPHDeciphera Pharmaceuticals, Inc.Kelly Thomas PatrickChief Financial OfficerSep 08, 2020Sale$23.6912,000284,26913,040Sep 10, 2020, 08:29 PM
DCPHDeciphera Pharmaceuticals, Inc.Kelly Thomas PatrickChief Financial OfficerSep 10, 2020Option Exercise$24.806,000148,79610,040Sep 10, 2020, 08:29 PM
DCPHDeciphera Pharmaceuticals, Inc.Hoerter Steven L.President and CEOAug 20, 2020Option Exercise$25.401874,75042,767Aug 24, 2020, 04:00 PM
DCPHDeciphera Pharmaceuticals, Inc.Flynn Daniel LeeChief Scientific OfficerAug 10, 2020Option Exercise$1.899,02917,065237,475Aug 12, 2020, 04:00 PM
DCPHDeciphera Pharmaceuticals, Inc.Flynn Daniel LeeChief Scientific OfficerJul 22, 2020Option Exercise$1.89130,000245,700228,446Jul 24, 2020, 04:00 PM
DCPHDeciphera Pharmaceuticals, Inc.Hoerter Steven L.President and CEOJul 20, 2020Option Exercise$25.401884,77542,580Jul 22, 2020, 04:00 PM
DCPHDeciphera Pharmaceuticals, Inc.Bristol James ArthurDirectorJul 09, 2020Option Exercise$28.4447,0821,339,12623,541Jul 13, 2020, 04:11 PM
DCPHDeciphera Pharmaceuticals, Inc.Taylor Michael DouglasDirectorJul 02, 2020Sale$29.2996,4902,826,14848,245Jul 06, 2020, 06:16 PM
DCPHDeciphera Pharmaceuticals, Inc.Taylor Michael DouglasDirectorJul 06, 2020Sale$28.5555,0881,572,93127,544Jul 06, 2020, 06:16 PM
DCPHDeciphera Pharmaceuticals, Inc.Taylor Michael DouglasDirectorJul 01, 2020Option Exercise$30.3898,4222,989,89849,211Jul 06, 2020, 06:16 PM
DCPHDeciphera Pharmaceuticals, Inc.Hoerter Steven L.President and CEOJun 18, 2020Option Exercise$25.401874,75042,392Jun 19, 2020, 04:00 PM
DCPHDeciphera Pharmaceuticals, Inc.Allen Patricia LDirectorJun 03, 2020Sale$42.4412,730540,2216,365Jun 05, 2020, 04:05 PM
DCPHDeciphera Pharmaceuticals, Inc.Allen Patricia LDirectorJun 05, 2020Sale$40.8211,270459,9875,635Jun 05, 2020, 04:05 PM
DCPHDeciphera Pharmaceuticals, Inc.Hoerter Steven L.President and CEOMay 28, 2020Option Exercise$25.401884,77542,205Jun 01, 2020, 04:05 PM
DCPHDeciphera Pharmaceuticals, Inc.Kelly Thomas PatrickChief Financial OfficerMay 11, 2020Sale$28.5424,000684,92019,040May 13, 2020, 04:05 PM
DCPHDeciphera Pharmaceuticals, Inc.Taylor Michael DouglasDirectorApr 28, 2020Sale$29.3950,0001,469,74025,000Apr 30, 2020, 04:05 PM
DCPHDeciphera Pharmaceuticals, Inc.Hoerter Steven L.President and CEOApr 21, 2020Option Exercise$25.401874,75042,017Apr 23, 2020, 04:10 PM
DCPHDeciphera Pharmaceuticals, Inc.Taylor Michael DouglasDirectorApr 17, 2020Option Exercise$24.2847,7841,160,30523,892Apr 21, 2020, 04:05 PM
DCPHDeciphera Pharmaceuticals, Inc.Taylor Michael DouglasDirectorApr 14, 2020Option Exercise$24.302,21653,8471,108Apr 16, 2020, 04:05 PM
DCPHDeciphera Pharmaceuticals, Inc.Bristol James ArthurDirectorApr 09, 2020Sale$22.8647,0841,076,33423,542Apr 13, 2020, 07:47 PM
DCPHDeciphera Pharmaceuticals, Inc.Taylor Michael DouglasDirectorApr 01, 2020Sale$19.73150,0002,959,30875,000Apr 03, 2020, 04:10 PM
DCPHDeciphera Pharmaceuticals, Inc.Hoerter Steven L.President and CEOMar 18, 2020Option Exercise$25.402,25057,15054,250Mar 20, 2020, 05:49 PM
DCPHDeciphera Pharmaceuticals, Inc.Hoerter Steven L.President and CEOMar 19, 2020Option Exercise$37.4912,420465,61949,756Mar 20, 2020, 05:49 PM
DCPHDeciphera Pharmaceuticals, Inc.Allen Patricia LDirectorJan 24, 2020Sale$35.0450,0001,752,07525,000Jan 28, 2020, 04:13 PM
DCPHDeciphera Pharmaceuticals, Inc.Martin Daniel C.Chief Commercial OfficerJan 22, 2020Sale$51.6453,9982,788,37343,999Jan 24, 2020, 04:10 PM